Artesunate is a water-soluble, semi-synthetic artemisinin derivative administered intravenously as the WHO-preferred first-line treatment for severe malaria. Simson Pharma's Artesunate reference standard and impurities support the stringent QC required of this life-saving parenteral antimalarial.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Artesunate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
